Trial intelligence / Profile preview

Tacrolimus vs Hydrocortisone in Pediatric Atopic Dermatitis

NCT05607901Phase 2Completed

Sponsor
Tanta University
Start
Nov 2022
Primary completion
Aug 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Tacrolimus Ointment 0.1% Iwaki in atopic dermatitis (AD), sponsored by Tanta University. Started Nov 2022; status: completed.

02

Drugs

Tacrolimus Ointment 0.1% Iwaki
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on NCT05607901.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05607901.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call